Taiyo Holdings Co., Ltd.
Notice of Personnel Changes
As of April 1, 2026, Executive Senior Managing Officer Eiji Sato will be appointed Director of Taiyo Pharma Co., Ltd., and Terumichi Tawara will be transferred to Director of the same company.
Key Figures
- Effective Date: 2026年4月1日
- New Director: Eiji Sato
- Director Transfer Destination: Taiyo Pharma Co., Ltd., Fanlead Co., Ltd., Taiyo Pharmatech Co., Ltd.
AI要約
Overview of Personnel Changes
Taiyo Holdings Co., Ltd. resolved at the Board of Directors meeting held on February 4, 2026, the personnel changes effective April 1, 2026. Executive Senior Managing Officer Eiji Sato will be appointed Director of Taiyo Pharma Co., Ltd., and concurrently serve as Director of Fanlead Co., Ltd. and Taiyo Pharmatech Co., Ltd. Meanwhile, Terumichi Tawara will continue as Executive Senior Managing Officer, Chief Digital Officer, and head of the Information Systems Department, while transferring to Director of Taiyo Pharma Co., Ltd.
Future Impact and Procedures
Appointments and resignations will be conducted once necessary procedures at each subsidiary are completed. These personnel changes aim to strengthen the management structure and promote digital strategy, contributing to the company's sustainable growth. Investors will focus on the stability of business operations and the clarification of strategic directions resulting from this management refresh.
